Peer review reports
From: Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma
Original Submission |
20 Sep 2023 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
23 Oct 2023 |
Author responded |
Author comments - Feng Jin
|
Resubmission - Version 4 |
23 Oct 2023 |
Submitted |
Manuscript version 4
|
25 Oct 2023 |
Author responded |
Author comments - Feng Jin
|
Resubmission - Version 5 |
25 Oct 2023 |
Submitted |
Manuscript version 5
|
8 Nov 2023 |
Author responded |
Author comments - Feng Jin
|
Resubmission - Version 6 |
8 Nov 2023 |
Submitted |
Manuscript version 6
|
24 Apr 2024 |
Reviewed |
Reviewer Report
|
25 Apr 2024 |
Reviewed |
Reviewer Report
|
30 Apr 2024 |
Author responded |
Author comments - Feng Jin
|
Resubmission - Version 7 |
30 Apr 2024 |
Submitted |
Manuscript version 7
|
Publishing |
2 May 2024 |
Editorially accepted |
|
6 May 2024 |
Article published |
10.1186/s12865-024-00621-3
|
Learn about peer review